GlassScriptPhysician profile
Brian D Heyman
NPI 1902856289
$1,726.12
in general payments reported to CMS, 2019-2025
29 companies · $72.91 in 2025
The $72.91 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $261 · 2020: $366 · 2021: $500 · 2022: $202 · 2023: $246 · 2024: $77.48 · 2025: $72.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renovia INC | $545.94 | 2019-2021 | |
| Abbvie INC. | $189.10 | 2020-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.17 | 2022-2023 | |
| Coopersurgical, INC. | $88.55 | 2021-2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $87.91 | 2022-2025 | |
| Daiichi Sankyo INC. | $83.57 | 2023-2024 | Injectafer |
| Aspira Women'S Health INC | $75.00 | 2021 | |
| Allergan, INC. | $53.52 | 2019-2020 | |
| Duchesnay USA Incorporated | $51.98 | 2019 | |
| Axonics, INC. | $50.54 | 2023-2024 | Axonics |
| Smith+Nephew, INC. | $44.56 | 2019-2023 | Pico |
| Alydia Health | $43.08 | 2021 | |
| Sumitomo Pharma America, INC. | $35.13 | 2023 | Myfembree, Gemtesa |
| Organon LLC | $33.28 | 2021-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $24.77 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $23.36 | 2019 | |
| Avion Pharmaceuticals | $19.96 | 2021 | |
| Myovant Sciences INC. | $19.60 | 2021 | |
| Amag Pharmaceuticals, INC. | $18.10 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $18.06 | 2023 | Kristalose |
| Hologic Sales and Service, LLC | $17.39 | 2021 | |
| Mylan Pharmaceuticals INC. | $16.90 | 2021 | |
| Medtronic, INC. | $16.59 | 2022 | |
| Distalmotion US | $15.07 | 2025 | Dexter L6 Robot |
| Ethicon US, LLC | $14.50 | 2023 | Stratafix, Dermabond, Vistaseal |
| Alexion Pharmaceuticals, INC. | $14.00 | 2019 | |
| Agile Therapeutics, INC. | $13.97 | 2021 | |
| Millicent US INC | $11.44 | 2020 | |
| Evofem Biosciences, INC. | $11.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Heyman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.